共 655 条
[1]
Parisi GF(2013)Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients BMC Res Notes 6 461-586
[2]
Cutello S(2016)YKL-40 as marker of severe lung disease in cystic fibrosis patients J Cyst Fibros 15 583-1638
[3]
Di Dio G(2018)Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease J Breath Res 12 026010-102
[4]
Rotolo N(2019)Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: case reports and literature review J Allergy Clin Immunol Pract 7 1636-1756
[5]
La Rosa M(2011)Recommendations for the classification of diseases as CFTR-related disorders J Cyst Fibros 10 S86-1664
[6]
Leonardi S(2019)Etiological involvement of CFTR in apparently unrelated human diseases Mol Cell Oncol 75 1737-1082
[7]
Leonardi S(2018)Cystic fibrosis transmembrane conductance regulator-emerging regulator of cancer Cell Mol Life Sci 148 1658-1086
[8]
Parisi GF(2021)Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank Int J Cancer 43 1078-1687
[9]
Capizzi A(2020)Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population Eur Respir J 47 1078-4270
[10]
Manti S(2014)CFTR, SPINK1, PRSS1, and CTRC mutations are not associated with pancreatic cancer in German patients Pancreas 42 1680-1127